NCT07017439View on ClinicalTrials.gov

Investigating the Adjunctive Use of Mirabegron in the Early Post-Rezum Procedure Period

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Benign Prostate Hypertrophy(BPH)
Interventions
DRUG

Beta-3 agonists (Mirabegron/Myrbetriq)

Patients in this arm will receive the medication in pill form following their procedure

OTHER

Placebo group post rezum

Patients in this arm will receive the placebo pill following their procedure.

Trial Locations (1)

R3P 2S8

Men's Health Clinic Manitoba, Winnipeg

All Listed Sponsors
lead

University of Manitoba

OTHER